Time-dependent Activation of ERK1/2 in Nerve Terminals of the Dentin-Pulp Complex following Bradykinin Treatment

Abstract

The extracellular signal-regulated kinases 1 and 2 (ERK1/2) have been implicated in the inflammation-dependent sensitization of nociceptors, and the inflammatory mediator bradykinin (BK) led to a reduced threshold in the nociceptor terminals, activating intracellular signaling by phosphorylating receptors and ion channels. The effects of BK on the non-transcriptional modulation of the ERK1/2 in the peripheral nociceptor terminals, including in nerve endings of the dentin-pulp complex, are unknown. The time-dependent effects of BK (10⁻⁷ M) on the ERK1/2 phosphorylation in nerve terminals of the dentin-pulp complex were investigated by quantitative and double immunolabeling with organ bath experiments. In nerve terminals, total and p-ERK1/2 were detected. In comparison with the controls, the numbers of p-ERK1/2-positive nerve endings increased after 1 and 3 min and decreased after 10 min of BK treatment. Analysis of the data indicates that BK induces phosphorylation-mediated local activation of ERK1/2 in nerve terminals modulating nociception in the dentin-pulp complex.

Get full access to this article

View all access options for this article.

References

Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO -2001-. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 21:6933–6939.

Amaya F, Wang H, Costigan M, Allchorne AJ, Hatcher JP, Egerton J, et al. -2006-. The voltage-gated sodium channel Na_v1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 26:12852–12860.

Bhave G, Gereau RW IV -2004-. Posttranslational mechanisms of peripheral sensitization. J Neurobiol 61:88–106.

Byers MR -1984-. Dental sensory receptors. Int Rev Neurobiol 25:39–94.

Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H, et al. -2002-. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci 22:7737–7745.

Fields RD, Eshete F, Stevens B, Itoh K -1997-. Action potential-dependent regulation of gene expression: temporal specificity in Ca²⁺ cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling. J Neurosci 17:7252–7266.

Goodis HE, Bowles WR, Hargreaves KM -2000-. Prostaglandin E2 enhances bradykinin-evoked iCGRP release in bovine dental pulp. J Dent Res 79:1604–1607.

Hirokawa N, Takemura R -2005-. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 6:201–214.

Ji RR -2004-. Mitogen-activated protein kinases as potential targets for pain killers. Curr Opin Investig Drugs 5:71–75.

10.

Ji RR, Woolf CJ -2001-. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8:1–10.

11.

Ji RR, Baba H, Brenner GJ, Woolf CJ -1999-. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2:1114–1119.

12.

Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ -2002-. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57–68.

13.

Ji RR, Kohno T, Moore KA, Woolf CJ -2003-. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26: 696–705.

14.

Julius D, Basbaum AI -2001-. Molecular mechanisms of nociception. Nature 413:203–210.

15.

Klinz FJ, Herberg N, Arnhold S, Addicks K, Bloch W -2007-. Phospho-eNOS Ser1176 is associated with the nucleoli and the Golgi complex in C6 rat glioma cells. Neurosci Lett 421:224–228.

16.

Korkmaz Y, Bloch W, Steinritz D, Baumann MA, Addicks K, Schneider K, et al. -2006-. Bradykinin mediates phosphorylation of eNOS in odontoblasts. J Dent Res 85:536–541.

17.

Obata K, Noguchi K -2006-. BDNF in sensory neurons and chronic pain. Neurosci Res 55:1–10.

18.

Obata K, Yamanaka H, Dai Y, Tachibana T, Fukuoka T, Tokunaga A, et al. -2003-. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 23:4117–4126.

19.

Oh EJ, Weinreich D -2004-. Bradykinin decreases K⁺ and increases Cl⁻ conductances in vagal afferent neurones of the guinea pig. J Physiol 558-Pt 2-:513–526.

20.

Regoli D, Barabe J -1980-. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46.

21.

Steranka LR, Manning DC, DeHaas CJ, Ferkany JW, Borosky SA, Connor JR, et al. -1988-. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci USA 85:3245–3249.

22.

Sugiura T, Tominaga M, Katsuya H, Mizumura K -2002-. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 88:544–548.

23.

Thomas GM, Huganir RL -2004-. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173–183.

24.

Walker K, Perkins M, Dray A -1995-. Kinins and kinin receptors in the nervous system. Neurochem Int 26:1–16.

25.

Wang H, Ehnert C, Brenner GJ, Woolf CJ -2006-. Bradykinin and peripheral sensitization. Biol Chem 387:11–14.

26.

Yung Y, Dolginov Y, Yao Z, Rubinfeld H, Michael D, Hanoch T, et al. -1997-. Detection of ERK activation by a novel monoclonal antibody. FEBS Lett 408:292–296.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.70 MB

0.00 MB